Analyzing Methotrexate’s Impact on Oxidative Stress Indicators in Breast Cancer Cells
Open Access
- 19 August 2025
- journal article
- Published by AVES YAYINCILIK A.Ş. in Cerrahpasa Medical Journal
- Vol. 49 (1) , 1-7
Abstract
Objective: Methotrexate (MTX) is one of the most commonly used antiproliferative chemotherapeutic agents. In addition to its antiproliferative effect, MTX may also play a role in the induction of oxidative stress. This study investigates the effects of MTX on cell cytotoxicity and oxidative stress markers (superoxide dismutase [SOD] activity, malondialdehyde [MDA] levels), and total thiol content) in both human healthy breast cells (hTERT-HME1) and human breast cancer cells (MCF-7). Methods: The hTERT-HME1 and MCF-7 cell lines were divided into untreated control and MTX groups. The cell viability assay was carried out using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. Superoxide dismutase, MDA, and total thiol levels were measured spectrophotometrically. Results: The effects of MTX on cell viability were observed after treatment of hTERT-HME1 and MCF-7 for 24, 48, and 72 hours. In comparison to MCF-7 cells, hTERT-HME1 cells exhibited increased cell survival and half-maximum inhibitory concentration 50 values after MTX treatment. Methotrexate administration also significantly decreased SOD and total thiol levels and increased MDA levels in both cell types. Conclusion: This study suggests that MTX has high anticancer activity through its effects on cell viability and oxidative stress. However, observation of similar effects in healthy cells requires the development of various combination therapies or targeted drug delivery systems to reduce the side effects of MTX. Cite this article as: Durmuş S, Ergün DD, Gelişgen R, Bakır N, Uzun H. Analyzing methotrexate’s impact on oxidative stress indicators in breast cancer cells. Cerrahpaşa Med J 2025, 49, 0007, doi: 10.5152/cjm.2025.25007.Keywords
This publication has 37 references indexed in Scilit:
- Methotrexate-based PROTACs as DHFR-specific chemical probesCell Chemical Biology, 2023
- Molecular toxicity of methotrexate in rheumatoid arthritis treatment: A novel perspective and therapeutic implicationsToxicology, 2021
- Breast cancer: insights in disease and influence of drug methotrexateRSC Medicinal Chemistry, 2020
- Mitochondrial dysfunction and oxidative stress are involved in the mechanism of methotrexate-induced renal injury and electrolytes imbalanceBiomedicine & Pharmacotherapy, 2018
- Hepatoprotective effect of berberine against methotrexate induced liver toxicity in ratsBiomedicine & Pharmacotherapy, 2018
- Direct antioxidant properties of methotrexate: Inhibition of malondialdehyde-acetaldehyde-protein adduct formation and superoxide scavengingRedox Biology, 2017
- Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challengesAnalytical Biochemistry, 2017
- Cancer metabolism and oxidative stress: Insights into carcinogenesis and chemotherapy via the non-dihydrofolate reductase effects of methotrexateBBA Clinical, 2015
- Methotrexate—how does it really work?Nature Reviews Rheumatology, 2010
- Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2EMBO Molecular Medicine, 2009